Compare TR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TR | TMDX |
|---|---|---|
| Founded | 1896 | 1998 |
| Country | United States | United States |
| Employees | 2100 | N/A |
| Industry | Specialty Foods | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.6B |
| IPO Year | N/A | 2019 |
| Metric | TR | TMDX |
|---|---|---|
| Price | $39.63 | $83.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $148.22 |
| AVG Volume (30 Days) | 148.0K | ★ 937.7K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | N/A | $24.25 |
| Revenue Next Year | N/A | $18.75 |
| P/E Ratio | ★ $32.36 | $131.49 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $34.44 | $60.11 |
| 52 Week High | $45.06 | $156.00 |
| Indicator | TR | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.28 | 58.69 |
| Support Level | $37.02 | $66.18 |
| Resistance Level | $40.29 | $140.79 |
| Average True Range (ATR) | 1.06 | 4.14 |
| MACD | 0.12 | 0.63 |
| Stochastic Oscillator | 76.35 | 79.36 |
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.